164 related articles for article (PubMed ID: 34426178)
1. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease.
Pan MX; Zheng CY; Deng YJ; Tang KR; Nie H; Xie JQ; Liu DD; Tu GF; Yang QH; Zhang YP
J Integr Med; 2021 Sep; 19(5):428-438. PubMed ID: 34426178
[TBL] [Abstract][Full Text] [Related]
2. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Shenling Baizhu Powder on treatment of alcoholic liver disease by regulating TLR4/NLRP3 pathway].
Cai SQ; Zhou SF; Zhou LF; Li YR; Zhou XY; Lyu FY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1275-1285. PubMed ID: 38621975
[TBL] [Abstract][Full Text] [Related]
4. Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice.
Yao Z; Guo J; Du B; Hong L; Zhu Y; Feng X; Hou Y; Shi A
Front Microbiol; 2023; 14():1147067. PubMed ID: 37538846
[TBL] [Abstract][Full Text] [Related]
5. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
[TBL] [Abstract][Full Text] [Related]
6. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.
Mu J; Cheng F; Wang Q; Wang X; Zhu W; Ma C; Yin X; Ren B; Lian Y; Du X; Zhang H; Liu S; Zhang S
J Tradit Chin Med; 2020 Apr; 40(2):253-266. PubMed ID: 32242391
[TBL] [Abstract][Full Text] [Related]
7. [Shenling Baizhu Powder alleviates chronic inflammation to prevent type 2 diabetes of ZDF rats via intestinal flora].
Zhang LJ; Zhan LB; Hang TY; Luo JT; Zhao CY
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):988-1000. PubMed ID: 35285199
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of Shenling Baizhu Powder on treatment of ulcerative colitis based on NLRP3 inflammatory].
Liu YH; Rong ZL; Zhu HY; Li YT; You Y
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5863-5871. PubMed ID: 36472005
[TBL] [Abstract][Full Text] [Related]
9. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
[TBL] [Abstract][Full Text] [Related]
10. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.
Gong XW; Xu YJ; Yang QH; Liang YJ; Zhang YP; Wang GL; Li YY
Chin J Integr Med; 2019 Mar; 25(3):216-224. PubMed ID: 29335857
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c.
Tang K; Deng Y; Zheng C; Nie H; Pan M; Chen R; Xie J; Yang Q; Zhang Y
Oxid Med Cell Longev; 2020; 2020():9701285. PubMed ID: 33062150
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
13. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Shenling Baizhu Powder in alleviation of ulcerative colitis in mice based on high-throughput transcriptome sequencing].
Sun J; Jiang XJ; Wang YD; Ma KL; Li ZH; Wang TC; Wang TM; Shao J; Wang CZ
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6155-6163. PubMed ID: 36471940
[TBL] [Abstract][Full Text] [Related]
15. Silybin inhibits NLRP3 inflammasome assembly through the NAD
Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
[TBL] [Abstract][Full Text] [Related]
16. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats.
Zhao H; Gao X; Liu Z; Zhang L; Fang X; Sun J; Zhang Z; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432531
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
[TBL] [Abstract][Full Text] [Related]
18. Chronic high-fat diet induces galectin-3 and TLR4 to activate NLRP3 inflammasome in NASH.
Li H; Cao Z; Wang L; Li J; Cheng X; Tang Y; Xing M; Yao P
J Nutr Biochem; 2023 Feb; 112():109217. PubMed ID: 36402251
[TBL] [Abstract][Full Text] [Related]
19. [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease].
Ma ZZ; Ao N; Yang N; Yang J; Jin S; Du C; Du J
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):624-630. PubMed ID: 36038324
[No Abstract] [Full Text] [Related]
20. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
